RSSDI Repository, Complications of Diabetes Demonstration RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

  • Home/
  • Article /
  • Finding the most cost-effective option from commonly used Dipeptidyl peptidase-4 inhibitors in India: a systematic study

Finding the most cost-effective option from commonly used Dipeptidyl peptidase-4 inhibitors in India: a systematic study

Add to Collection
Systematic Review and Meta Analysis H Singh, E Arora, S Narula, M Singla… - Expert Review of …, 2023 - Taylor & Francis

Chapter : Section3
Journal Year : 2023

… Five of the included studies were performed on Indian patients with T2DM [22-26… India. It is crucial to identify the safer and cost-effective anti-diabetic agents to provide the best treatment …..... Read More

Keywords : ["commonly use dipeptidyl inhibitor", "systematic study", "costeffective option", "india", "find"]
PubMed Link : https://www.tandfonline.com/doi/abs/10.1080/17446651.2023.2216279